Ionis Pharmaceuticals (IONS) Competitor Comparison
We are evaluating the key criteria listed to compare Ionis Pharmaceuticals (IONS) against its competitors in the Biotechnology industry.
Market Capitalization
28 / 368Gross Profits
269 / 278Total Revenue
23 / 300EBITDA
325 / 337Free Cashflow
342 / 352Quick Ratio
161 / 357Earnings per Share
235 / 359Dividend yield
0 / 6Total Cash
8 / 358Performance 3 years
91 / 368Performance 5 years
166 / 368Performance 10 years
123 / 368Linearity 3 years
23 / 368Linearity 5 years
96 / 368Linearity 10 years
54 / 368Total Rank
326 / 368Dividend Rank
170 / 368Valuation Rank
154 / 368Piotroski Rank
365 / 368Muliplier Rank
127 / 368EBITDA - IONS ranking 325 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.